In last trading session, GRI Bio Inc (NASDAQ:GRI) saw 0.33 million shares changing hands with its beta currently measuring -2.15. Company’s recent per share price level of $0.41 trading at -$0.03 or -4.64% at ring of the bell on the day assigns it a market valuation of $3.71M. That closing price of GRI’s stock is at a discount of -3229.27% from its 52-week high price of $13.65 and is indicating a premium of 26.83% from its 52-week low price of $0.30.

GRI Bio Inc (NASDAQ:GRI) trade information

Upright in the red during last session for losing -4.64%, in the last five days GRI remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.41 price level, adding 31.66% to its value on the day. GRI Bio Inc’s shares saw a change of -49.90% in year-to-date performance and have moved -23.15% in past 5-day. GRI Bio Inc (NASDAQ:GRI) showed a performance of -38.24% in past 30-days.

GRI Bio Inc (GRI) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.64% during past 5 years.

On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 53.65 shares of worth $22264.0 or 0.60% of the total outstanding shares. The later fund manager was in possession of 9.16 shares on Dec 31, 2024 , making its stake of worth around $3802.0 in the company or a holder of 0.10% of company’s stock.